Although larger studies in other populations are needed, it is likely that adverse blood lipid profiles in carriers of the FTO rs9939609 SNP A-allele are mediated by adiposity, suggesting obesity prevention and treatment strategies should be paramount in improving the blood lipid profiles of FTO risk allele carriers. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.